Literature DB >> 1386060

Characterization of the progeny of precursor-T (pre-T) cells maintained in vitro by interleukin-3 (IL-3). Development of T-cell function in vivo.

R S Soloff1, D Dempsey, S R Jennings, R M Wolcott, R Chervenak.   

Abstract

We have recently described a bone marrow culture system which is able to maintain a portion of the precursor-T (pre-T) cell compartment of adult murine marrow in vitro, in the presence of interleukin-3 (IL-3), for at least 2 weeks. However, because growth in IL-3 might also induce the differentiation of the pre-T cells, it is necessary to determine the extent to which the developmental potential of the pre-T cells is altered during their residency in vitro. Previously, we analysed the progeny of cultured pre-T cells and compared their intrathymic development, their appearance in the periphery, and their V beta gene utilization to that of the progeny of fresh pre-T cells. Within these parameters, the cells derived from cultured marrow cells did not differ significantly from cells derived from fresh marrow cells. However, these studies did not allow us to determine the functional status of the T-cell progeny of cultured marrow. In the work presented here, we analysed the functional potential of T cells which were derived either from fresh pre-T cells or pre-T cells which had been maintained for 1 week in vitro. The T-cell mediated functions analysed included mitogen- and alloantigen-induced proliferation, IL-2 production, and generation of cytotoxic T cells. We found that the cultured pre-T cells were capable of giving rise to mature, immunocompetent T cells which did not differ significantly from the progeny of fresh pre-T cells in their functional potential.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1386060      PMCID: PMC1421525     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  29 in total

Review 1.  Early events in T-cell maturation.

Authors:  B Adkins; C Mueller; C Y Okada; R A Reichert; I L Weissman; G J Spangrude
Journal:  Annu Rev Immunol       Date:  1987       Impact factor: 28.527

2.  Conditions controlling the proliferation of haemopoietic stem cells in vitro.

Authors:  T M Dexter; T D Allen; L G Lajtha
Journal:  J Cell Physiol       Date:  1977-06       Impact factor: 6.384

3.  In vitro differentiation of B lymphocytes from primitive hemopoietic precursors present in long-term bone marrow cultures.

Authors:  K Dorshkind
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

Review 4.  The developmental biology of T lymphocytes.

Authors:  H von Boehmer
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

Review 5.  T cell selection in the thymus.

Authors:  J Sprent; D Lo; E K Gao; Y Ron
Journal:  Immunol Rev       Date:  1988-01       Impact factor: 12.988

Review 6.  Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex.

Authors:  J W Kappler; U Staerz; J White; P C Marrack
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

7.  Maturational state of lymphoid cells in long-term bone marrow cultures.

Authors:  K Dorshkind; R A Phillips
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

8.  Mature T cells generated from single thymic clones are phenotypically and functionally heterogeneous.

Authors:  G J Spangrude; I L Weissman
Journal:  J Immunol       Date:  1988-09-15       Impact factor: 5.422

9.  Properties and applications of monoclonal antibodies directed against determinants of the Thy-1 locus.

Authors:  A Marshak-Rothstein; P Fink; T Gridley; D H Raulet; M J Bevan; M L Gefter
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

10.  Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A-bearing antigen-presenting cell function.

Authors:  A M Kruisbeek; J J Mond; B J Fowlkes; J A Carmen; S Bridges; D L Longo
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.